ANCA-associated vasculitis

AR Kitching, HJ Anders, N Basu, E Brouwer… - Nature reviews Disease …, 2020 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a
group of disorders involving severe, systemic, small-vessel vasculitis and are characterized …

ANCA-associated vasculitis: an update

S Almaani, LA Fussner, S Brodsky, AS Meara… - Journal of clinical …, 2021 - mdpi.com
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) represents a group
of small vessel vasculitides characterized by granulomatous and neutrophilic tissue …

KDIGO 2021 clinical practice guideline for the management of glomerular diseases

BH Rovin, SG Adler, J Barratt, F Bridoux… - Kidney …, 2021 - kidney-international.org
Glomerular disease, be it primary or secondary, occurring in the setting of systemic
autoimmune diseases, infections, drugs, or malignancy, affects individuals of all ages. In …

[HTML][HTML] EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

B Hellmich, B Sanchez-Alamo, JH Schirmer… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …

[HTML][HTML] Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated …

K Gulati, H Edwards, M Prendecki, TD Cairns… - Kidney International, 2021 - Elsevier
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis can present with life-
threatening lung-kidney syndromes. However, many controlled treatment trials excluded …

Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside

B Brilland, AS Garnier, A Chevailler, P Jeannin… - Autoimmunity …, 2020 - Elsevier
Anti-neutrophil cytoplasmic autoantibodies (ANCA)-associated vasculitides (AAVs) are small
vessel vasculitides involving predominantly ear-nose-throat, kidneys, lungs and nerves …

Management of ANCA associated vasculitis

ZS Wallace, EM Miloslavsky - Bmj, 2020 - bmj.com
Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a small to
medium vessel vasculitis associated with excess morbidity and mortality. This review …

ANCA-associated vasculitis—refining therapy with plasma exchange and glucocorticoids

VK Derebail, RJ Falk - New England Journal of Medicine, 2020 - Mass Medical Soc
Plasma exchange has been a mainstay of induction therapy for patients with antineutrophil
cytoplasmic antibody (ANCA)–associated vasculitis who have rapidly progressive …

Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of …

JH Schirmer, B Sanchez-Alamo, B Hellmich… - RMD open, 2023 - rmdopen.bmj.com
Objective To summarise and update evidence to inform the 2022 update of the EULAR
recommendations for the management of antineutrophil cytoplasm antibody-associated …

The efficacy and safety of rituximab in ANCA-associated vasculitis: a systematic review

MA Habibi, S Alesaeidi, M Zahedi, S Hakimi Rahmani… - Biology, 2022 - mdpi.com
Simple Summary ANCA-associated vasculitis (AAV) is a rare disease and manifests in
different organs. The exact mechanism of AAV is not fully understood, but it is speculated …